Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancer-Reference-Cited by-同舟云学术

Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancer

Published:2022-01 Issue: Volume: Page:
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Cho Young‐Won¹²^ORCID,Min Dong‐Wook¹²,Kim Hwang‐Phill¹²^ORCID,An Yohan³,Kim Sheehyun⁴⁵,Youk Jeonghwan⁶,Chun Jaeyoung⁷⁸,Im Jong Pil⁷,Song Sang‐Hyun²,Ju Young Seok³⁶,Han Sae‐Won⁴,Park Kyu Joo⁹,Kim Tae‐You¹²⁴

Affiliation:

1. Department of Molecular Medicine & Biopharmaceutical Sciences Graduate School of Convergence Science and Technology Seoul National University Korea

2. Cancer Research Institute Seoul National University Korea

3. BioMedical Science and Engineering Interdisciplinary Program (BSEIP) Korea Advanced Institute of Science and Technology Daejeon Korea

4. Department of Internal Medicine Seoul National University Hospital Korea

5. Department of Translational Medicine Seoul National University College of Medicine Korea

6. Graduate School of Medical Science & Engineering (GSMSE) Korea Advanced Institute of Science and Technology Daejeon Korea

7. Department of Internal Medicine and Liver Research Institute Seoul National University College of Medicine Korea

8. Department of Internal Medicine Gangnam Severance Hospital Yonsei University College of Medicine Seoul Korea

9. Department of Surgery Seoul National University College of Medicine Korea

Funder

Korea Health Industry Development Institute

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13144

Reference56 articles.

1. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche

2. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers

3. Optical Metabolic Imaging Identifies Glycolytic Levels, Subtypes, and Early-Treatment Response in Breast Cancer

4. A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening

5. Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in validation of combination treatment strategies for CRC using patient-derived organoids;Journal of Experimental & Clinical Cancer Research;2024-09-11

2. Advancements in Research and Treatment Applications of Patient-Derived Tumor Organoids in Colorectal Cancer;Cancers;2024-07-26

3. 3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation;Biofabrication;2024-06-07

4. Cancer research revolutionized: Unveiling the power of organoids and their therapeutic potential in oncology;hLife;2024-05

5. Overcoming limitations in current measures of drug response may enable AI-driven precision oncology;npj Precision Oncology;2024-04-24